Bio-based cellulose moves to industrial supply as Seprify raises €13.4m

Seprify
Flagship product grades include SilvaLuma™, a cellulose-based SPF booster for cosmetics and personal care, and SilvaAlba™, a food‑grade whitening solution designed as a scalable alternative to titanium dioxide. (Seprify)

It appears that cellulose alternatives for cosmetics are accelerating.

Key takeaways

  • Seprify has transitioned its cellulose platform from pilot validation to procurement-ready industrial supply.
  • The company has raised €13.4m in Series A funding, including investment from Inter IKEA Group.
  • Its flagship products, SilvaLuma™ and SilvaAlba™, target demand for bio-based alternatives to titanium dioxide.
  • Funding will support scale-up to hundreds of tonnes per year and expanded commercial rollout.
  • Seprify rolls out procurement-ready cellulose for industry

Swiss bio-materials company Seprify has moved from pilot validation to repeatable supply, supported by a €13.4m Series A funding round, which includes investment from Inter IKEA Group.

With the funding, the company will be able to move its cellulose platform from pilot validation into procurement-ready industrial supply.

This shift will meet growing demand for scalable, bio-based alternatives to high-emiss include SilvaLuma™, a cellulose-based SPF booster for cosmetics and personal care, and SilvaAlba™, a food‑grade whitening solution designed as a scalable alternative to titanium dioxide.

Investment fuels commercial expansion and manufacturing readiness

Seprify said that its cellulose platform has been validated at Technology Readiness Level (TRL) 7–9 through collaboration with industry partners. The company is currently working with more than 100 customer organisations, ranging from active evaluations to early commercial supply.

The Series A round includes participation from Inter IKEA Group, alongside Una Terra Early Growth Fund, Zürcher Kantonalbank (ZKB), Cambridge Enterprise Ventures, Kickfund and other circular-economy-focused investors.

With the new investment, Seprify plans to scale commercial production to hundreds of tonnes per year through established manufacturing partners, support commercial rollout across its priority markets and advance engineering work for future industrial-scale capacity.

“This funding enables us to focus on execution and scale,” explained Lukas Schertel, Co-founder & CEO of Seprify.

“Our immediate priority is delivering consistent quality and reliable supply, meeting the operational standards large industrial customers require. In the near term, that means supporting cosmetics and personal care, including suncare.”